Impel Pharmaceuticals to Participate in Upcoming Investor
SEATTLE, March 03, 2023 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage
Globe Newswire4-03-2023, 04:03
The E-bike Market is anticipated to register a CAGR of 11-03-2023, 10:40